OraSure Technologies Operating Income 2011-2025 | OSUR
OraSure Technologies operating income from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
OraSure Technologies Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-28 |
| 2023 | $33 |
| 2022 | $-22 |
| 2021 | $-10 |
| 2020 | $-5 |
| 2019 | $19 |
| 2018 | $28 |
| 2017 | $40 |
| 2016 | $20 |
| 2015 | $8 |
| 2014 | $-5 |
| 2013 | $-12 |
| 2012 | $-16 |
| 2011 | $-9 |
| 2010 | $-3 |
|
OraSure Technologies Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-16 |
| 2025-06-30 | $-18 |
| 2025-03-31 | $-18 |
| 2024-12-31 | $-12 |
| 2024-09-30 | $-6 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $4 |
| 2023-09-30 | $11 |
| 2023-06-30 | $-6 |
| 2023-03-31 | $24 |
| 2022-12-31 | $15 |
| 2022-09-30 | $1 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-13 |
| 2021-06-30 | $2 |
| 2021-03-31 | $10 |
| 2020-12-31 | $8 |
| 2020-09-30 | $4 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-8 |
| 2019-12-31 | $4 |
| 2019-09-30 | $13 |
| 2019-06-30 | $5 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $13 |
| 2018-09-30 | $11 |
| 2018-06-30 | $6 |
| 2018-03-31 | $0 |
| 2017-12-31 | $10 |
| 2017-09-30 | $7 |
| 2017-06-30 | $7 |
| 2017-03-31 | $16 |
| 2016-12-31 | $7 |
| 2016-09-30 | $6 |
| 2016-06-30 | $4 |
| 2016-03-31 | $3 |
| 2015-12-31 | $4 |
| 2015-09-30 | $2 |
| 2015-06-30 | $3 |
| 2015-03-31 | $0 |
| 2014-12-31 | $-3 |
| 2014-09-30 | $1 |
| 2014-06-30 | $2 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $6 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-11 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-4 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-3 |
| 2010-12-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.172B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.724B | 25.32 |
| EssilorLuxottica (ESLOY) | France | $166.677B | 0.00 |
| Boston Scientific (BSX) | United States | $148.274B | 33.90 |
| Stryker (SYK) | United States | $136.154B | 27.03 |
| Medtronic (MDT) | Ireland | $118.264B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.513B | 0.00 |
| Agilent Technologies (A) | United States | $41.601B | 26.92 |
| ResMed (RMD) | United States | $36.703B | 25.40 |
| GE HealthCare Technologies (GEHC) | United States | $33.276B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $27.125B | 17.72 |
| Terumo (TRUMY) | Japan | $23.970B | 28.40 |
| Insulet (PODD) | United States | $22.513B | 69.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.183B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.253B | 7.47 |
| Bio-Rad Laboratories (BIO) | United States | $8.242B | 29.64 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.460B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $3.387B | 10.32 |
| Haemonetics (HAE) | United States | $3.200B | 14.24 |
| Envista Holdings (NVST) | United States | $3.198B | 18.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.883B | 13.15 |
| Perrigo (PRGO) | Ireland | $1.987B | 4.98 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.64 |
| Curaleaf Holdings (CURLF) | Canada | $1.793B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.774B | 17.72 |
| AtriCure (ATRC) | United States | $1.593B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.449B | 63.49 |
| Tilray Brands (TLRY) | Canada | $1.392B | 0.00 |
| Neogen (NEOG) | United States | $1.391B | 26.67 |
| QuidelOrtho (QDEL) | United States | $1.382B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $1.349B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 18.63 |
| BioLife Solutions (BLFS) | United States | $1.242B | 370.43 |
| InMode (INMD) | Israel | $0.913B | 10.32 |
| Valneva SE (VALN) | France | $0.750B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.497B | 17.10 |
| Verano Holdings (VRNO) | United States | $0.478B | 0.00 |
| SNDL (SNDL) | Canada | $0.468B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.425B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.328B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Owens & Minor (OMI) | United States | $0.246B | 2.47 |
| Viemed Healthcare (VMD) | United States | $0.242B | 19.30 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.206B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.22 |
| FitLife Brands (FTLF) | United States | $0.172B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.134B | 5.42 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Sharps Technology (STSS) | United States | $0.109B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 11.95 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Nephros (NEPH) | United States | $0.049B | 35.38 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |